Spain Over The Counter Otc Drugs Market: Market Size & Forecast 2026

Spain's OTC drug market sits within the country's broader pharmaceutical sector, which was valued at roughly USD 40 billion in 2025. Within that context, OTC medicines typically account for a mid-single-digit share of total pharma spending, consistent with their role as everyday self-care products. Sales occur predominantly through community pharmacies, which must be registered with AEMPS, while online channels are gradually expanding their share of revenue.

• •Market size estimated at USD 2.44 billion in 2025, with growth of about 5.15% annually.
• •Distribution dominated by licensed community pharmacies regulated by AEMPS.
• •Online pharmacies captured roughly 8.2% of OTC revenue in 2025.
• •Roughly 20% of the Spanish population reports using non-prescription medication.

Several structural factors are supporting consistent expansion of the Spanish OTC market. Demographic aging is increasing demand for treatments managing chronic but mild conditions, while consumers are increasingly comfortable treating minor ailments themselves rather than visiting a physician.

• •Aging population driving demand for pain, cardiovascular, and digestive self-care products.
• •Rising trend of self-medication and consumer interest in personal health management.
• •Switching of selected prescription medicines to OTC status broadening the available product range.
• •Gradual expansion of e-pharmacy platforms improving product accessibility.

The Spanish OTC market is typically segmented by product category, including analgesics, cough and cold remedies, digestive products, vitamins and dietary supplements, dermatologicals, and smoking-cessation aids, and by distribution channel. Within Spain, demand is relatively evenly distributed across autonomous communities, with somewhat higher per-capita consumption in urban regions such as Madrid, Catalonia, and Andalusia.

• •Analgesics and cold/cough remedies represent the leading product categories by sales.
• •Pharmacies remain the principal channel, followed by parapharmacies, supermarkets for selected lines, and online retailers.
• •Higher per-capita consumption tends to cluster in major metropolitan regions.
• •Distribution is broadening through digital and e-commerce platforms.

What are the recent trends and outlook?

Looking ahead, the Spanish OTC market is expected to continue growing steadily, supported by demographic and behavioral tailwinds. Digital health tools, expanded e-pharmacy offerings, and continued Rx-to-OTC switches are likely to shape the market's evolution through the end of the decade.

• •Steady projected growth at roughly 5% annually, taking the market toward USD 3 billion over the medium term.
• •Continued migration of certain prescription drugs to OTC status expected to expand product availability.
• •E-pharmacy and online retail channels likely to capture a growing share of sales.
• •Ongoing regulatory oversight by AEMPS and Ministry of Health pricing policies will continue to influence market dynamics.